Breastfeeding and GLP-1 Medications GLP-1 Medications and Breastfeeding: What Nursing Parents Need to Know Weight-loss medications like semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) have become increasingly common
Were talking about average weight loss of 24-29% in clinical trials, which is substantially more than what weve seen with semaglutide (Wegovy) or tirzepatide (Zepbound)
Understanding these differences helps patients choose a path that matches their goalsfat loss, muscle preservation, anti-aging, or metabolic healthwhile keeping safety and monitoring at the forefront
Mounjaro is highly effective for type 2 diabetes but costs over $1,000 per month without insurance, making affordability a major concern for uninsured or self-pay patients
Notably, some muscle groups, especially the rectus abdominis, psoas major, and paraspinal muscles, reportedly showed more evident changes